By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Rexahn Pharmaceuticals, Inc. 

15245 Shady Grove Road
Suite 455
Rockville  Maryland  20850  U.S.A.
Phone: 240-268-5300 Fax: 240-268-5310


SEARCH JOBS








Company News
Rexahn Pharmaceuticals, Inc. (RNN) Identifies RX-3117 Biomarker & Presents Data At The 2015 AACR Annual Meeting 4/20/2015 8:39:59 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present Data On RX-3117 And Supinoxin At The 2015 American Association for Cancer Research Annual Meeting 4/13/2015 7:57:36 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 12th Annual BIO Asia International Conference In Tokyo, Japan 3/18/2015 7:50:09 AM
Rexahn Pharmaceuticals, Inc. (RNN) Reports Fourth Quarter And Full-Year 2014 Financial Results And Pipeline Update 3/17/2015 7:42:41 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The BIO-Europe Spring 2015 Conference In Paris, France 3/4/2015 8:47:34 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The ROTH Capital Partners 27th Annual Growth Stock Conference 3/2/2015 7:50:12 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 3rd Annual Sachs Cancer Bio Partnering & Investment Forum In New York 2/18/2015 8:15:33 AM
Rexahn Pharmaceuticals, Inc. (RNN) Announces The Publication Of Preclinical Data For Supinoxin (RX-5902) Demonstrating Mechanism Of Action 2/9/2015 7:32:06 AM
Rexahn Pharmaceuticals, Inc. (RNN) Announces The Appointment Of Ely Benaim, M.D., As Chief Medical Officer 2/4/2015 8:13:41 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/2/2015 8:19:22 AM
12345678910...
//-->